These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7676548)

  • 1. [Fibrinogen and coronary heart disease].
    Kienast J
    Versicherungsmedizin; 1995 Aug; 47(4):122-6. PubMed ID: 7676548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen and homocysteine levels in coronary artery disease.
    Gheye S; Lakshmi AV; Krishna TP; Krishnaswamy K
    Indian Heart J; 1999; 51(5):499-502. PubMed ID: 10721639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
    N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the plasma fibrinogen concentration and coronary heart disease severity in Moroccan patients with type 2 diabetes. Prospective study.
    Kotbi S; Mjabber A; Chadli A; El Hammiri A; El Aziz S; Oukkache B; Mifdal H; Nourichafi N; Kamal N; Habbal R; Ghalim N; Farouqi A; Kabine M
    Ann Endocrinol (Paris); 2016 Oct; 77(5):606-614. PubMed ID: 26903037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma homocysteine levels and mortality in patients with coronary artery disease.
    Nygård O; Nordrehaug JE; Refsum H; Ueland PM; Farstad M; Vollset SE
    N Engl J Med; 1997 Jul; 337(4):230-6. PubMed ID: 9227928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Longitudinal studies on the prognostic significance of plasma fibrinogen in diabetes mellitus].
    Schmechel H; Beiküfner P; Panzram G
    Z Gesamte Inn Med; 1984 Sep; 39(18):453-7. PubMed ID: 6506821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
    Gardemann A; Schwartz O; Haberbosch W; Katz N; Weiss T; Tillmanns H; Hehrlein FW; Waas W; Eberbach A
    Thromb Haemost; 1997 Jun; 77(6):1120-6. PubMed ID: 9241743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinogen (Fb) concentrations in patients with ischaemic heart disease undergoing coronary angiography].
    Goracy I; Goracy J; Brykczyński M; Jastrzebska M; Naruszewicz M
    Pol Arch Med Wewn; 2001 Jul; 106(1):551-6. PubMed ID: 11928565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of fibrinogen to presence and severity of coronary artery disease is independent of other coexisting heart disease. The ECAT Angina Pectoris Study Group.
    Bolibar I; Kienast J; Thompson SG; Matthias R; Niessner H; Fechtrup C
    Am Heart J; 1993 Jun; 125(6):1601-5. PubMed ID: 8498300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of D-Dimers and fibrinogen plasma determination in patients with polyvascular disease.
    Bosevski M; Kostoska S; Tosev S; Borozanov V
    Angiol Sosud Khir; 2006; 12(2):9-15. PubMed ID: 17053757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma HMW fibrinogen in patients with ischaemic heart disease.
    Munkvad S; Nieuwenhuizen W; Jespersen J
    Scand J Clin Lab Invest; 1990 May; 50(3):347-9. PubMed ID: 2353165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers.
    de Maat MP; Pietersma A; Kofflard M; Sluiter W; Kluft C
    Atherosclerosis; 1996 Apr; 121(2):185-91. PubMed ID: 9125293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of coronary arteriography and left ventriculography in ischaemic heart disease.
    Vojácek J; Fabián J; Belán A
    Cor Vasa; 1982; 24(6):405-14. PubMed ID: 7184696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
    Cavusoglu Y; Gorenek B; Alpsoy S; Unalir A; Ata N; Timuralp B
    Isr Med Assoc J; 2001 Jan; 3(1):13-6. PubMed ID: 11344793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain.
    Heinrich J; Schulte H; Schönfeld R; Köhler E; Assmann G
    Thromb Haemost; 1995 Mar; 73(3):374-9. PubMed ID: 7667818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gelatinase B C(-1562)T polymorphism in relation to ischaemic heart disease.
    Haberbosch W; Gardemann A
    Scand J Clin Lab Invest; 2005; 65(6):513-22. PubMed ID: 16179285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of fibrinogen levels on angiographic progression and 12-year survival in the armed forces regression study.
    Devendra GP; Hart SA; Whitney EJ; Krasuski RA
    Angiology; 2010 May; 61(4):333-7. PubMed ID: 20304867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipids, lipoproteins, fibrinogen and fibrinolytic activity in angiographically assessed coronary heart disease.
    Lipinska I; Gurewich V; Meriam CM; Kosowsky BD; Ramaswamy K; Philbin E; Losordo D
    Artery; 1987; 15(1):44-60. PubMed ID: 3435252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictive value of fibrinogen and high-sensitivity C-reaction protein for cardiovascular events in patients with stable coronary artery disease].
    Huang W; Chen QW; Lei H; Deng W; Ke DZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):718-21. PubMed ID: 17081398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
    ; Danesh J; Lewington S; Thompson SG; Lowe GD; Collins R; Kostis JB; Wilson AC; Folsom AR; Wu K; Benderly M; Goldbourt U; Willeit J; Kiechl S; Yarnell JW; Sweetnam PM; Elwood PC; Cushman M; Psaty BM; Tracy RP; Tybjaerg-Hansen A; Haverkate F; de Maat MP; Fowkes FG; Lee AJ; Smith FB; Salomaa V; Harald K; Rasi R; Vahtera E; Jousilahti P; Pekkanen J; D'Agostino R; Kannel WB; Wilson PW; Tofler G; Arocha-Piñango CL; Rodriguez-Larralde A; Nagy E; Mijares M; Espinosa R; Rodriquez-Roa E; Ryder E; Diez-Ewald MP; Campos G; Fernandez V; Torres E; Marchioli R; Valagussa F; Rosengren A; Wilhelmsen L; Lappas G; Eriksson H; Cremer P; Nagel D; Curb JD; Rodriguez B; Yano K; Salonen JT; Nyyssönen K; Tuomainen TP; Hedblad B; Lind P; Loewel H; Koenig W; Meade TW; Cooper JA; De Stavola B; Knottenbelt C; Miller GJ; Cooper JA; Bauer KA; Rosenberg RD; Sato S; Kitamura A; Naito Y; Palosuo T; Ducimetiere P; Amouyel P; Arveiler D; Evans AE; Ferrieres J; Juhan-Vague I; Bingham A; Schulte H; Assmann G; Cantin B; Lamarche B; Després JP; Dagenais GR; Tunstall-Pedoe H; Woodward M; Ben-Shlomo Y; Davey Smith G; Palmieri V; Yeh JL; Rudnicka A; Ridker P; Rodeghiero F; Tosetto A; Shepherd J; Ford I; Robertson M; Brunner E; Shipley M; Feskens EJ; Kromhout D; Dickinson A; Ireland B; Juzwishin K; Kaptoge S; Lewington S; Memon A; Sarwar N; Walker M; Wheeler J; White I; Wood A
    JAMA; 2005 Oct; 294(14):1799-809. PubMed ID: 16219884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.